Vanguard Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Vanguard Capital Management's AMPH Position: Q3 2026 in Review
Vanguard Capital Management reduced its Amphastar Pharmaceuticals (AMPH) stake by 16% in Q3 2026, selling an estimated $5.24M and leaving 1,239,347 shares worth $32M. The position accounts for ﹤0.01% of the portfolio, ranked #2141.
Vanguard Capital Management first reported a position in AMPH in Q1 2026 and has held it in 3 quarters since. 227 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.
- Vanguard Capital Management held 1,239,347 shares of Amphastar Pharmaceuticals worth $32M as of Q3 2026.
- Vanguard Capital Management sold 242,605 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $5.24M.
- Amphastar Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2141 holding.
- Vanguard Capital Management first reported a position in Amphastar Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 227 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.